ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $230,000 | +360.0% | 12,198 | +183.1% | 0.00% | – |
| Q2 2019 | $50,000 | -86.7% | 4,309 | -84.4% | 0.00% | -100.0% |
| Q1 2019 | $377,000 | +9325.0% | 27,663 | +5913.7% | 0.00% | – |
| Q4 2018 | $4,000 | -97.1% | 460 | -94.5% | 0.00% | – |
| Q3 2018 | $140,000 | -29.6% | 8,409 | -33.3% | 0.00% | -100.0% |
| Q2 2018 | $199,000 | +114.0% | 12,614 | +55.2% | 0.00% | -75.0% |
| Q4 2017 | $93,000 | +63.2% | 8,126 | +74.3% | 0.00% | +100.0% |
| Q3 2017 | $57,000 | -83.6% | 4,661 | -84.7% | 0.00% | -86.7% |
| Q2 2017 | $347,000 | +1234.6% | 30,369 | +2298.8% | 0.02% | +1400.0% |
| Q1 2017 | $26,000 | – | 1,266 | +4265.5% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 29 | -90.2% | 0.00% | – |
| Q2 2016 | $7,000 | -97.9% | 296 | -97.8% | 0.00% | -100.0% |
| Q1 2016 | $332,000 | +219.2% | 13,564 | +329.2% | 0.03% | +225.0% |
| Q4 2015 | $104,000 | -86.4% | 3,160 | -86.5% | 0.01% | -85.7% |
| Q3 2015 | $764,000 | +594.5% | 23,346 | +1023.5% | 0.06% | +522.2% |
| Q2 2015 | $110,000 | – | 2,078 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |